Navepegritide
Protein
Overview
Navepegritide is a protein active pharmaceutical ingredient (ChEMBL CHEMBL4594507).
Patent & exclusivity (US)
Per the FDA Orange Book (3 approved US products), the latest listed US patent on Navepegritide expires 12 Nov 2042 and exclusivity 27 Feb 2033. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.